All posts tagged "ATTAIN-2"

Eli Lilly’s Orforglipron Achieves 10.5% Weight Loss in Diabetics

Eli Lilly has announced the results of its third phase 3 trial for the oral weight-loss medication orforglipron, paving the way for regulatory submissions worldwide. In...